GHK-Cu: the copper tripeptide, copper included

GHK-Cu is a copper-carrying peptide with an unusually clear origin story. The peptide part, glycyl-histidyl-lysine, was first isolated from human plasma, where its concentration was noticed to fall with age. On its own that tripeptide binds copper ions tightly, and the copper complex is what most research actually studies. In skin and connective-tissue biology it is examined for effects on collagen, the extracellular matrix and gene expression in fibroblasts, which is why it turns up in both the peptide literature and cosmetic chemistry.

For laboratory research use only. Not for human or veterinary use.

What the molecule actually is

GHK-Cu is not a plain peptide but a metallopeptide: the tripeptide Gly-His-Lys (GHK) coordinated to a copper(II) ion. The histidine side chain and the terminal amino group give the peptide a geometry that wraps around Cu2+ with high affinity, so the complex behaves as a copper-delivery species rather than a simple chain. That copper is central to the biology, because many of the enzymes GHK is linked to are themselves copper-dependent and cannot function without the metal.

The complex has a molecular formula of C14H22CuN6O4 and a molecular weight near 401.9 g/mol, noticeably heavier than the free peptide because of the coordinated metal. It is usually supplied as a blue-tinted powder, the colour coming directly from the copper. As always, the salt form and the exact copper loading recorded on a certificate of analysis define the real mass of a given lot, and the free peptide (GHK without copper) is a different material with different behaviour.

Verified molecule

• Sequence (1-letter): GHK (as the copper(II) complex)
• Molecular formula: C14H22CuN6O4
• Molecular weight: 401.91 g/mol
• CAS number: 89030-95-5
• Class: copper(II) metallopeptide complex of Gly-His-Lys

What the literature examines

The best-known work comes from Loren Pickart, who first isolated GHK from plasma in the 1970s and has argued for decades that it acts as a signal for tissue remodelling. Research in fibroblast culture links the copper complex to collagen and elastin synthesis, to modulation of matrix metalloproteinases (the enzymes that break down the extracellular matrix) and their inhibitors, and to broad changes in gene expression. A 2018 review by Pickart and Margolina in the International Journal of Molecular Sciences pulled this together with gene-array data, describing shifts across hundreds of genes in cultured cells exposed to the peptide.

The through-line is copper biology and matrix turnover. Copper is a required cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin, so a peptide that delivers copper into cells has an obvious route to influence connective-tissue structure. Much of the interest in skin research follows from that. Collagen density, matrix remodelling and antioxidant enzyme activity are common endpoints in the published assays, and the gene-expression work tries to explain those observations at the level of transcription.

The gene-expression angle is what sets the recent GHK-Cu literature apart. Rather than reporting a single pathway, the newer work uses expression profiling to map how cultured cells respond across many genes at once, including genes tied to matrix rebuilding, antioxidant defence and cell signalling. Whether every one of those shifts is biologically meaningful is an open question, and gene-array data are notoriously easy to over-interpret. Still, the scale of the reported response is one reason the peptide keeps drawing renewed interest decades after it was first described in plasma.

A note on the copper

It is worth dwelling on the metal, because it is the feature that makes GHK-Cu distinct. GHK binds Cu2+ in a specific coordination geometry, and that binding is not incidental packaging: it is arguably the whole point. Copper is a tightly controlled trace element in living systems, and delivering it in a chelated, peptide-bound form is chemically very different from tipping a copper salt into a dish. The studies that carry the most weight are the ones that compare the intact complex against the free peptide and against copper alone, because those comparisons are what isolate the contribution of the assembled GHK-Cu species rather than its parts.

Where it came from

GHK was identified in the mid-1970s as a factor in human plasma that changed how aged tissue behaved in culture. Pickart's early work tied the activity to copper binding, and the field grew from there into skin biology and matrix research. Because the copper complex is stable and easy to handle, it became a staple of both peptide research and cosmetic formulation, and it now carries a long paper trail relative to newer research peptides, which is part of why it is often used as a reference point.

Honest limitations

The clearest limitation is context. Much of the strongest GHK-Cu data is in cell culture, where the peptide is applied directly to fibroblasts, and gene-array results in a dish do not automatically carry over to living tissue. Copper itself is a double-edged variable. It is essential in trace amounts but reactive in excess, so the balance within the complex matters and free copper is not the same thing as chelated copper.

There is also the identity question. GHK and GHK-Cu are different molecules, and a copper-free peptide will not behave like the copper complex. Suppliers vary in how carefully they specify copper content, so a certificate of analysis that states the copper loading and salt form is far more useful than a bare product name. As with any metallopeptide, mass spectrometry alongside elemental analysis is the dependable check on identity.

A final point on interpretation. GHK-Cu has a longer and better-documented record than most research peptides, which is a real advantage, but it also means older claims circulate freely and are sometimes repeated without the caveats attached to the original work. The stronger reading is that the copper-delivery and matrix-remodelling story is well supported in fibroblast culture, and that extending it any further is a matter for careful, current experiments rather than for confidence borrowed from the peptide's long history.

Common questions

What is GHK-Cu?

It is the copper(II) complex of the tripeptide glycyl-histidyl-lysine, a sequence first isolated from human plasma. In research it is studied as a copper-delivery molecule and a modulator of collagen synthesis, matrix enzymes and gene expression in fibroblast culture.

How does GHK-Cu differ from plain GHK?

GHK is the bare tripeptide; GHK-Cu is that peptide bound to a copper ion. The copper is not an optional extra, since much of the studied biology depends on copper delivery, so the two are best handled as distinct materials with different molecular weights.

How is it stored?

The powder is generally kept dry, cold and out of light, and reconstituted solution is held cold and used within a short window. Because the copper complex can be sensitive to pH and oxidation, the buffer and storage conditions on the lot certificate of analysis take priority over any general rule.

References

1. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018.